ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,168, issued on Nov. 25, was assigned to Binx Health Ltd. (Trowbridge, Great Britain).
"Detection methods" was invented by Danny Filer (Bristol, Great Britain), Claire Ferrao (Trowbridge, Great Britain) and Sharon Chadwick (Trowbridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of detecting the presence of Neisseria gonorrhoeae in a sample. The method involves detecting a first target sequence taken from the NGO1642 gene and/or a second target sequence taken from the NGO1012 gene. The method may involve a step of amplifying the target sequence and may involve hybridising the target sequence to a nucleic acid probe and ident...